{"id":9453,"date":"2026-07-03T12:48:03","date_gmt":"2026-07-03T12:48:03","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/regional-consultation-on-vaccine-and-immunization-research-preparedness-for-vaccine-preventable-disease-vpd-outbreaks-and-pandemics-14-16-april-2026-new-delhi-india\/"},"modified":"2026-07-03T12:48:03","modified_gmt":"2026-07-03T12:48:03","slug":"regional-consultation-on-vaccine-and-immunization-research-preparedness-for-vaccine-preventable-disease-vpd-outbreaks-and-pandemics-14-16-april-2026-new-delhi-india","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/regional-consultation-on-vaccine-and-immunization-research-preparedness-for-vaccine-preventable-disease-vpd-outbreaks-and-pandemics-14-16-april-2026-new-delhi-india\/","title":{"rendered":"Regional Consultation on Vaccine and Immunization Research Preparedness for Vaccine Preventable Disease (VPD) Outbreaks and Pandemics, 14\u201316 April 2026, New Delhi, India"},"content":{"rendered":"


\n<\/p>\n

\n
\n
\n
\n \"Regional
\n <\/figure>\n
Download (2.8 MB)<\/span><\/a><\/div><\/div>\n
\n
\n
\n
\n

Overview <\/h3>\n

COVID-19 revealed that the Region\u2019s challenge was not vaccine development speed, but
\nthe timely generation of context-specific evidence on effectiveness, safety, delivery, and
\ncommunity acceptance. Research was reactive, fragmented, and hampered by diverging
\nregulatory requirements, incompatible protocols, and an infodemic that eroded public
\ntrust. Recurrent outbreaks of measles, Nipah, dengue, and diphtheria \u2014 including an active
\nmeasles outbreak in Bangladesh at the time of this consultation \u2014 underscore that research
\npreparedness is a permanent, not a pandemic-era, priority.<\/p>\n

With this context, the WHO South-East Asia Regional Office (SEARO) and CEPI co-hosted a
\nthree-day Regional Consultation from 14 to 16 April 2026 in New Delhi, bringing together
\nmore than 90 participants (both face-to-face and virtual) from all Member States, the SEARITAG, vaccine manufacturers, academic institutions, regulatory authorities, and
\ndevelopment partners. The consultation aimed to strengthen vaccine and immunization
\nresearch readiness during outbreaks and pandemics in the WHO South-East Asia Region by
\ndeveloping a framework for a responsive, well-governed, and collaborative immunization
\nresearch ecosystem. <\/p>\n

For this Regional Consultation, WHO SEARO developed a draft framework for Vaccine and
\nImmunization Research Preparedness, organized around six pillars \u2014 Basic Science
\nResearch; Clinical and Epidemiological Research; Health Research Governance; Vaccine
\nMarket and Manufacturing Research; Implementation Research; and Behavioural, Social,
\nand Communication Research \u2014 supported by five common enablers: data sharing,
\ndigitalization and AI, funding mechanisms, collaborations, and knowledge sharing. The
\nframework\u2019s overarching goal is to establish a ready-to-activate, coordinated, and resilient
\nresearch ecosystem enabling rapid, equitable, and effective responses to VPD outbreaks
\nand pandemics, while simultaneously strengthening routine immunization systems. <\/p>\n

The inaugural session highlighted the urgent need for a robust and ready immunization
\nresearch ecosystem in the Region. Dr Catharina Boehme emphasized gaps in timely
\nevidence generation during COVID-19 and the potential of the 100-Day Mission. Dr Kent
\nKester reaffirmed CEPI\u2019s partnership with WHO SEARO under CEPI 3.0, keeping the 100-Day
\nMission as the strategic north star. Dr Rajiv Bahl showcased India\u2019s readiness infrastructure
\n\u2014 the One Health Mission, INTENT trial network, and BSL-4 laboratories \u2014 as potential
\nregional assets. Prof. VK Paul, in his chief guest remarks, called on the Region to respond to
\nthe next pandemic \u201cnot scrambling, but with pre-established, well-tested, coordinated
\nsystems\u201d. He also urged WHO to prioritize research and support in strengthening the
\nresearch ecosystem in the Region.<\/p>\n<\/p><\/div><\/div>\n

\n
\n
\n
WHO Team<\/div>\n
\n
\nCommunicable Diseases, <\/span>
\n
\nImmunization & Vaccines Development, <\/span>
\n
\nSEARO Regional Office for the South East Asia (RGO), <\/span>
\n
\nWHO South-East Asia <\/span>\n <\/div><\/div>\n
\n
Editors<\/div>\n
World Health Organization. Regional Office for South-East Asia\t<\/div><\/div>\n
\n
Number of pages<\/div>\n
60<\/div><\/div>\n
\n
Reference numbers<\/div>\n
\n
WHO Reference Number: <\/strong>SEA-HDC-4<\/span><\/div><\/div><\/div>\n
\n
Copyright<\/div>\n


\n
\n
\n
\n
\n <\/a>\n <\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n


\n
Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"

Download (2.8 MB) Overview COVID-19 revealed that the Region\u2019s challenge was not vaccine development speed, but the timely generation of context-specific evidence on effectiveness, safety, delivery, and community acceptance. Research was reactive, fragmented, and hampered by diverging regulatory requirements, incompatible protocols, and an infodemic that eroded public trust. Recurrent outbreaks of measles, Nipah, dengue, and diphtheria \u2014 including an active…<\/p>","protected":false},"author":99035,"featured_media":9454,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[1148,1278,2888,1898,1536,761,2372,2887,2199,1533,1096,1250,995,2886],"ground_category":[315,316],"class_list":["post-9453","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-april","tag-consultation","tag-delhi","tag-disease","tag-immunization","tag-india","tag-outbreaks","tag-pandemics","tag-preparedness","tag-preventable","tag-regional","tag-research","tag-vaccine","tag-vpd","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/627cfe5f-5d38-4872-8da0-632282a4c25a\/content","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=9453"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9453\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/9454"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=9453"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=9453"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=9453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}